Status:

UNKNOWN

Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial

Lead Sponsor:

University of British Columbia

Collaborating Sponsors:

United States Department of Defense

Conditions:

Acute Spinal Cord Injury

Spinal Cord Injuries

Eligibility:

All Genders

17+ years

Phase:

NA

Brief Summary

The study involves the 'first-in-human' evaluation of a novel optical sensor which uses near-infrared spectroscopy (NIRS) technology to assess oxygenation and hemodynamics of the injured spinal cord. ...

Detailed Description

This single-center, prospective observational study will enroll 10 patients admitted to Vancouver General Hospital (VGH) for treatment of an acute traumatic spine injury. Promising preclinical data d...

Eligibility Criteria

Inclusion

  • Male or female aged 17 years or older
  • Spinal injury between bony levels C3 and L1 inclusive
  • Motor complete acute traumatic SCI (AIS A or B) or motor incomplete SCI (AIS C) with a total lower extremity motor score of less than 5
  • Blunt (non-penetrating) SCI requiring posterior laminectomy with stabilization/fusion surgery within 72 hours of injury
  • Able to communicate in English and provide informed consent

Exclusion

  • Isolated radiculopathy or cauda equina injury
  • Spinal cord impairment secondary to tumour, infection, epidural bleeding, or ischemia (in
  • Any condition or injury (e.g. Morel-Lavellee lesion) that would interfere with the application or readings of the NIRS sensor
  • Associated traumatic condition that would interfere with the informed consent process or outcome assessments (e.g. traumatic brain injury, pelvic, abdominal, or thoracic injuries)
  • Any other medical condition that, in the investigator's opinion, would render the protocol procedures dangerous
  • Female patients who are pregnant

Key Trial Info

Start Date :

September 24 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2024

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04811235

Start Date

September 24 2022

End Date

September 30 2024

Last Update

July 3 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vancouver General Hospital

Vancouver, British Columbia, Canada, V5Z1M9